Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ILMN

Illumina Inc

Dec 11 • 04:00PM ET

147.64

Dollar change -0.89
Percentage change -0.60	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: PACB VRTX TXG QGEN GH BIO MYGN IONS TWST OMIC

| Held by: IJH VTI VO QQQ VXF VUG MDY VOT IBB IJJ

Scroll to Statements

Index	NDX	P/E	-	EPS (ttm)	-10.00	Insider Own	0.76%	Shs Outstand	158.00M	Perf Week	3.61%
Market Cap	23.42B	Forward P/E	33.40	EPS next Y	4.42	Insider Trans	0.00%	Shs Float	157.39M	Perf Month	-2.55%
Income	-1585.00M	PEG	-	EPS next Q	0.92	Inst Own	99.78%	Short Float	4.58%	Perf Quarter	16.94%
Sales	4.39B	P/S	5.33	EPS this Y	393.09%	Inst Trans	1.32%	Short Ratio	3.77	Perf Half Y	40.00%
Book/sh	13.45	P/B	10.98	EPS next Y	7.25%	ROA	-19.65%	Short Interest	7.21M	Perf Year	29.14%
Cash/sh	5.92	P/C	24.94	EPS next 5Y	13.00%	ROE	-39.51%	52W Range	97.27 - 156.66	Perf YTD	9.11%
Dividend Est.	-	P/FCF	42.89	EPS past 5Y	-	ROI	-33.54%	52W High	-5.76%	Beta	1.11
Dividend TTM	-	Quick Ratio	1.85	Sales past 5Y	7.40%	Gross Margin	63.96%	52W Low	51.79%	ATR (14)	5.24
Dividend Ex-Date	-	Current Ratio	2.43	EPS Y/Y TTM	-40.00%	Oper. Margin	22.19%	RSI (14)	56.37	Volatility	4.08% 3.62%
Employees	12010	Debt/Eq	1.26	Sales Y/Y TTM	-1.68%	Profit Margin	-36.10%	Recom	2.07	Target Price	164.00
Option/Short	Yes / Yes	LT Debt/Eq	1.22	EPS Q/Q	192.33%	Payout	-	Rel Volume	0.98	Prev Close	148.53
Sales Surprise	0.00%	EPS Surprise	29.75%	Sales Q/Q	-3.49%	Earnings	Nov 04 AMC	Avg Volume	1.91M	Price	147.64
SMA20	4.48%	SMA50	2.59%	SMA200	17.30%	Trades		Volume	1,863,724	Change	-0.60%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Downgrade	Citigroup	Buy → Neutral	$190 → $165
Nov-12-24	Resumed	Morgan Stanley	Equal-Weight	$156
Oct-17-24	Upgrade	HSBC Securities	Hold → Buy	$180
Aug-28-24	Upgrade	Argus	Hold → Buy
Aug-16-24	Upgrade	Daiwa Securities	Neutral → Buy	$120 → $154
Aug-14-24	Upgrade	TD Cowen	Hold → Buy	$126 → $144
Aug-14-24	Upgrade	Barclays	Underweight → Equal Weight	$125
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$140
Jun-03-24	Resumed	Jefferies	Hold	$115
Jan-16-24	Downgrade	HSBC Securities	Buy → Hold
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$144
Dec-18-23	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$185
Dec-15-23	Upgrade	Bernstein	Underperform → Mkt Perform
Dec-14-23	Initiated	Stephens	Overweight	$170
Dec-14-23	Initiated	Guggenheim	Buy	$155
Dec-13-23	Initiated	Wolfe Research	Outperform	$175
Dec-12-23	Downgrade	BofA Securities	Neutral → Underperform	$140 → $100
Dec-11-23	Upgrade	Citigroup	Sell → Neutral	$85 → $120
Nov-10-23	Downgrade	Canaccord Genuity	Buy → Hold	$210 → $120
Sep-28-23	Initiated	Bernstein	Underperform	$111

Show Previous Ratings

Dec-10-24 03:00PM	Independent Testing Proves Dragen Provides a Vastly More Comprehensive Genome (ACCESSWIRE)
Dec-04-24 04:07PM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
11:30AM	Illumina (ILMN) Down 9.3% Since Last Earnings Report: Can It Rebound? (Zacks)
03:30AM	Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications (PR Newswire)
Nov-25-24 05:41PM	Illumina, Inc. (ILMN): Constrained Spending in Pharmaceutical Industry Pressures Shares Despite Strong Niche Position (Insider Monkey)
03:40PM	Loading…
Nov-22-24 03:40PM	Trailblazing Study Shows Early CGP Leads to Better Precision Treatments (ACCESSWIRE)
Nov-20-24 04:30PM	Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina's Updated Comprehensive Gene Panel Assay, TruSight Oncology 500 v2 (GlobeNewswire)
03:29PM	If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer (Barrons.com)
10:43AM	Analyst Report: Illumina, Inc. (Morningstar Research)
07:57AM	Illumina gear up to expand TruSight Oncology portfolio (Medical Device Network)
Nov-19-24 09:15AM	Illumina announces expansion of TruSight Oncology portfolio (PR Newswire)
Nov-18-24 09:16AM	Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now? (Insider Monkey)
Nov-11-24 11:59PM	Illumina, Inc. (ILMN): Unlocking Growth Potential in Genetic Testing and Robotics (Insider Monkey)
09:50AM	Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term (Zacks)
Nov-08-24 09:40AM	Heres Why You Should Invest in Illumina (ILMN) (Insider Monkey)
09:15AM	Loading…
Nov-07-24 09:15AM	Interpreting Illumina (ILMN) International Revenue Trends (Zacks)
12:04AM	Decoding Illumina Inc (ILMN): A Strategic SWOT Insight (GuruFocus.com)
Nov-06-24 04:05PM	Illumina To Webcast Upcoming Investor Conferences (PR Newswire)
Nov-05-24 08:40AM	Q3 2024 Illumina Inc Earnings Call (Thomson Reuters StreetEvents)
02:08AM	Illumina Inc (ILMN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Nov-04-24 11:31PM	Analyst Report: Illumina, Inc. (Morningstar Research)
07:30PM	Illumina (ILMN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:50PM	Illumina (ILMN) Tops Q3 Earnings and Revenue Estimates (Zacks)
04:53PM	Illumina: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024 (PR Newswire)
Oct-31-24 09:15AM	Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting (PR Newswire)
Oct-30-24 09:15AM	What Analyst Projections for Key Metrics Reveal About Illumina (ILMN) Q3 Earnings (Zacks)
Oct-28-24 10:01AM	Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-23-24 10:00PM	Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers (PR Newswire)
Oct-22-24 05:33PM	Corvex founder Meister sees big upside for stocks already targeted by others (Reuters)
10:06AM	Loading…
Oct-16-24 10:06AM	Is this the Best Time to Add Illumina (ILMN)? (Insider Monkey)
Oct-11-24 08:18AM	Illumina launches new benchtop NGS system (Medical Device Network)
Oct-09-24 12:10PM	Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers (PR Newswire)
Oct-08-24 09:50AM	Here's Why Illumina (ILMN) is a Strong Momentum Stock (Zacks)
Oct-07-24 04:05PM	Illumina to Announce Third Quarter 2024 Financial Results on Monday, November 4, 2024 (PR Newswire)
Oct-03-24 05:46PM	Charles Dadswell to step down as General Counsel, Illumina initiates search for successor (PR Newswire)
Oct-02-24 09:23AM	Illumina, Inc. (ILMN): A Bull Case Theory (Insider Monkey) +7.78%
Sep-19-24 02:00AM	Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture (PR Newswire)
Sep-17-24 01:14AM	Illumina, Inc. (NASDAQ:ILMN): A Non-Tech Stock With Long-Term Investment Potential (Insider Monkey)
Sep-13-24 03:48PM	Goldman Thinks Illumina, Inc. (ILMN) Is A Long-Term AI Stock Set To Rally Eventually (Insider Monkey)
Sep-10-24 07:00AM	Bull of the Day: Illumina (ILMN) (Zacks)
Sep-03-24 11:37AM	Illumina Wins Court Fight With EU Over $7 Billion Grail Deal (Bloomberg)
07:20AM	Illumina avoids fine for Grail purchase in European court victory (MedTech Dive)
07:13AM	EU court backs Illumina and dismisses challenge over Grail acquisition (Medical Device Network)
06:43AM	Europes Top Court Rebukes Competition Regulator, Curbing Powers (The Wall Street Journal)
03:59AM	European Court of Justice rules in favor of Illumina in jurisdictional appeal (PR Newswire)
03:50AM	Illumina wins Grail battle in blow to EU merger power (Reuters)
Aug-29-24 04:16PM	Results of GRAIL's Galleri Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology (PR Newswire)
Aug-28-24 09:34AM	Illumina upgraded, Fiserv initiated: Wall Street's top analyst calls (The Fly)
06:32AM	FDA grants approval to Illuminas cancer biomarker test with two CDx indications (Medical Device Network)
01:06AM	Illumina wins FDA approval for companion diagnostic cancer test (MedTech Dive)
Aug-27-24 09:15AM	FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies (PR Newswire)
Aug-26-24 11:20AM	Is the Options Market Predicting a Spike in Illumina (ILMN) Stock? (Zacks)
Aug-23-24 06:00AM	Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG) (News Direct)
Aug-17-24 10:05PM	Illumina, Inc. (ILMN): Is This Cheap Robotic Stock a Good Buy Right Now? (Insider Monkey)
Aug-16-24 08:01PM	10 Cheap Robotics Stocks To Buy (Insider Monkey)
Aug-15-24 07:14PM	Analyst Report: Illumina, Inc. (Morningstar Research) +5.33%
Aug-14-24 09:33AM	Starbucks, Chipotle upgraded: Wall Street's top analyst calls (The Fly)
07:55AM	Illumina, Inc. (ILMN) Faces Activist Pressure By Icahn Enterprises (Insider Monkey)
Aug-13-24 03:24PM	Analyst Report: Illumina, Inc. (Morningstar Research)
11:00AM	Illumina announces strategy to accelerate value creation (PR Newswire)
Aug-12-24 09:15AM	Understanding Illumina (ILMN) Reliance on International Revenue (Zacks)
08:43AM	Illumina (ILMN) Beats on Q2 Earnings, Lowers 2024 Sales View (Zacks)
Aug-08-24 01:03AM	Decoding Illumina Inc (ILMN): A Strategic SWOT Insight (GuruFocus.com)
Aug-07-24 12:38PM	Analyst Report: Illumina, Inc. (Morningstar Research)
Aug-06-24 07:00PM	Compared to Estimates, Illumina (ILMN) Q2 Earnings: A Look at Key Metrics (Zacks)
06:54PM	Illumina expects full-year sales from core segment to decline on biotech funding crunch (Reuters)
06:25PM	Illumina (ILMN) Q2 Earnings and Revenues Top Estimates (Zacks)
05:30PM	Illumina: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Illumina Reports Financial Results for Second Quarter of Fiscal Year 2024 (PR Newswire)
Aug-05-24 09:50AM	Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term (Zacks)
09:15AM	Illumina launches new oncology menu for NovaSeq X Series customers (PR Newswire)
Aug-01-24 09:15AM	Stay Ahead of the Game With Illumina (ILMN) Q2 Earnings: Wall Street's Insights on Key Metrics (Zacks)
09:14AM	Q2 2024 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-30-24 10:01AM	Illumina (ILMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Jul-24-24 08:55AM	Heres Why You Should Add Illumina (ILMN) to Your Portfolio (Insider Monkey)
Jul-22-24 12:10PM	Why Illumina (ILMN) Could Beat Earnings Estimates Again (Zacks)
09:55AM	Wall Street Analysts Think Illumina (ILMN) Could Surge 27.02%: Read This Before Placing a Bet (Zacks)
Jul-21-24 11:49PM	10x Genomics, Inc. (TXG): Hedge Funds Think This Stock Will Skyrocket (Insider Monkey)
06:00AM	3 Precision Medicine Stocks Tailoring Treatments (InvestorPlace)
Jul-19-24 03:02AM	Should You Consider Adding Illumina (ILMN) to Your Portfolio? (Insider Monkey)
Jul-18-24 04:05PM	Illumina to Present Upcoming Strategy Update (PR Newswire)
Jul-16-24 07:51PM	Analyst Report: Illumina, Inc. (Morningstar Research) +7.44%
12:00PM	Illumina (ILMN) Upgraded to Buy: Here's Why (Zacks)
Jul-15-24 12:31PM	3 Spinoff Stocks You Should Buy Now: July 2024 (InvestorPlace)
Jul-12-24 07:45AM	Element raises $277M to challenge Illumina in sequencing market (MedTech Dive)
06:32AM	Illumina sees stock spike after acquisition of Fluent BioSciences (Medical Device Network)
Jul-11-24 04:05PM	Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 (PR Newswire)
Jul-10-24 02:10PM	Illumina Deal Sends 10x Genomics Stock Tumbling (Barrons.com) +6.08%
10:53AM	Illumina (ILMN) Buys Fluent, Grows in Single Cell Research (Zacks)
12:51AM	Illumina buys Fluent Biosciences, adding single-cell analysis tech (MedTech Dive)
Jul-09-24 04:05PM	Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base (PR Newswire)
03:22PM	3 Of the Best ETFs to Buy for AI Stocks Exposure (InvestorPlace)
Jul-08-24 09:00AM	The 3 Best Gene Editing Stocks to Buy in July 2024 (InvestorPlace)
Jul-05-24 06:55AM	3 Biotech Stocks Turning DNA Dreams Into Dollars (InvestorPlace)
Jul-03-24 07:00AM	The 3 Best Personalized Medicine Stocks to Buy in July 2024 (InvestorPlace)
Jun-28-24 11:00AM	Illumina Takes a $1.47 Billion Charge Related to Its GRAIL Spinoff (Investopedia)
Jun-25-24 11:26AM	Illumina (ILMN) Rises on Conclusion of GRAIL Divestment (Zacks)
11:12AM	GRAL Stock Alert: 7 Things to Know as Grail Starts Trading Today (InvestorPlace)
10:41AM	Analyst Report: Illumina, Inc. (Morningstar Research)

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CHARLES E. DADSWELL TRUST U/A/	Officer	Oct 14 '24	Proposed Sale	145.54	4,948	720,132		Oct 15 08:03 AM
CHARLES E. DADSWELL TRUST U/A/	Officer	Aug 15 '24	Proposed Sale	122.28	3,956	483,740		Aug 15 04:31 PM
Thaysen Jacob	Chief Executive Officer	Feb 22 '24	Buy	135.29	7,330	991,672	14,861	Feb 26 08:57 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ILMN

Illumina Inc

Upgrade your FINVIZ experience